Metformina Teva Italia

Metformin, the active ingredient in Metformina Teva Italia, is a Biguanide presented as a tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients. The drug improves glycemic control by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity.

GNH USA supplies Metformina Teva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for bulk manufacturing, quality assurance and regulatory support.

Metformina Teva Italia (metformin) is used in the management of disorders related to glucose metabolism.

Type 2 diabetes mellitus: lowers blood glucose levels and improves overall glycemic control. Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. Polycystic ovary syndrome: reduces insulin resistance and may improve ovulatory function.

Metformina Teva Italia may be associated with a range of adverse reactions, classified by frequency.

Common Side Effects: - Nausea: feeling of sickness often occurring early in therapy. - Diarrhea: loose stools that may be transient. - Metallic taste: temporary alteration in taste perception. - Abdominal discomfort: mild stomach pain or cramping.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When prescribing Metformina Teva Italia, clinicians should consider several safety measures.

Renal function: assess eGFR before initiating and monitor periodically. Liver disease: use with caution in patients with hepatic impairment. Alcohol consumption: avoid excessive intake to reduce lactic acidosis risk. Risk of lactic acidosis: discontinue if patient develops severe hypoxia, sepsis or organ failure. Pregnancy and lactation: evaluate risk‑benefit and consider alternative therapy. Store at room temperature: keep in original container, protect from moisture and heat.

Metformina Teva Italia can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal impairment and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: excessive intake heightens lactic acidosis potential.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics (especially thiazides): affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.